Baal Nelli, Reisinger Kerstin, Jahr Henning, Bohle Rainer M, Liang Olin, Münstedt Karsten, Rao C V, Preissner Klaus T, Zygmunt Marek T
Department of Obstetrics, Justus-Liebig-University, Giessen, Germany.
Thromb Haemost. 2004 Oct;92(4):767-75. doi: 10.1160/TH04-02-0079.
A significant number of hematopoietic stem/progenitor cells (HSPC) in human umbilical cord blood could serve as a reservoir for the placental vasculature, yet, their morphological and functional features are not completely understood. Here, we describe the characterization of purified CD133(+) progenitor cells from umbilical cord blood, a subset of CD34(+) hematopoietic progenitors that were grown in proliferation medium containing Flt3-ligand, thrombopoietin and stem cell factor. Following isolation and enrichment of the CD133(+) cells by immunomagnetic cell sorting, they remained non-adherent for up to 40 days in culture and expressed different pluripotency markers including Sox-1, Sox-2, FGF-4, Rex-1 and Oct-4.Oct-4 expression was confirmed by laser-assisted single cell picking with subsequent quantitative real-time RT-PCR. The expression of Oct-4 indicates a pluripotent phenotype of CD133(+) cells and appears to be of functional relevance: After three weeks in endothelial differentiation medium, suspended cells became adherent, developed an endothelial cell-like morphology, bound fluoresceine isothiocyanate-labeled Ulex europaeus agglutinin-1, took up acetylated Di-LDL, and expressed other endothelial markers such as PECAM-1 or VEGFR-2. Concomitantly, Oct-4 expression was significantly reduced. Moreover, following treatment with retinoic acid, CD133(+) cells exhibited neural morphology associated with the expression of beta-III-tubulin. CD133(+) cells were found to express the luteinizing hormone/human chorionic gonadotropin (LH/hCG) receptor, detected by RT-PCR and immunocytochemistry. The recombinant human chorionic gonadotropin induced proliferation of the CD133(+) cells in a dose-specific manner. Our results indicate that CD133(+) HSPC from umbilical cord blood may have a greater differentiation potential than previously recognized and give rise to proliferative endothelial cells participating in placental vasculogenesis.
人类脐带血中大量的造血干/祖细胞(HSPC)可作为胎盘血管系统的储备,但它们的形态和功能特征尚未完全明确。在此,我们描述了从脐带血中纯化的CD133(+)祖细胞的特征,CD133(+)祖细胞是CD34(+)造血祖细胞的一个亚群,在含有Flt3配体、血小板生成素和干细胞因子的增殖培养基中生长。通过免疫磁珠细胞分选法分离和富集CD133(+)细胞后,它们在培养中长达40天保持不贴壁,并表达包括Sox-1、Sox-2、FGF-4、Rex-1和Oct-4在内的不同多能性标志物。通过激光辅助单细胞挑选及随后的定量实时RT-PCR证实了Oct-4的表达。Oct-4的表达表明CD133(+)细胞具有多能表型,并且似乎具有功能相关性:在内皮分化培养基中培养三周后,悬浮细胞开始贴壁,呈现出内皮细胞样形态,结合异硫氰酸荧光素标记的荆豆凝集素-1,摄取乙酰化的Di-LDL,并表达其他内皮标志物,如PECAM-1或VEGFR-2。与此同时,Oct-4的表达显著降低。此外,用视黄酸处理后,CD133(+)细胞呈现出与β-III-微管蛋白表达相关的神经形态。通过RT-PCR和免疫细胞化学检测发现CD133(+)细胞表达促黄体生成素/人绒毛膜促性腺激素(LH/hCG)受体。重组人绒毛膜促性腺激素以剂量特异性方式诱导CD133(+)细胞增殖。我们的结果表明,脐带血中的CD133(+) HSPC可能具有比先前认识到的更大的分化潜能,并产生参与胎盘血管生成的增殖性内皮细胞。